title: Establishment of bone marrow-derived endothelial cell lines from ts-SV40 T-antigen gene transgenic rats.
abstract: OBJECTIVE
  Postneonatal neovascularization is thought to result exclusively from the proliferation, migration, and remodeling of fully differentiated endothelial cells (ECs). Recently, it has been reported that bone marrow contains cells which can differentiate into ECs and contribute to neoangiogenesis in adult species. In this study, we tried to establish conditionally immortalized endothelial cell lines (TR-BME) derived from rat bone marrow.
  
  
  METHODS
  Mononuclear cells were isolated and differentiated into ECs at 37 degrees C from the bone marrow of a transgenic rat harboring temperature-sensitive SV40 large T-antigen (ts T-Ag) gene. Then, the cells were transferred and incubated at 33 degrees C, a permissive temperature for ts T-Ag. Expression of vascular endothelial growth factor (VEGF) receptor (VEGFR)-1, 2, Tie-1, 2 and von Willebrand factor (VWF) were assayed by reverse transcriptase-mediated polymerase chain reaction (RT-PCR).
  
  
  RESULTS
  We have established three cell lines incorporating 1,1'-dioctadecyl-3,3,3',3-tetramethylindo-carbocyanine perchlorate (DiI-Ac-LDL) with a spindle shape. One of these, clone 2, strongly expressed VEGFR-2, and weakly expressed VEGFR-1 and VWF. In contrast, clone 8 showed strong expression of Tie-1, 2, and VWF, and weak expression of VEGFR-1,2. All markers were expressed strongly in clone 3.
  
  
  CONCLUSIONS
  These data confirm that the above three TR-BME cells are novel ECs derived from bone marrow progenitors.
authors.affiliation: Department of Pharmaceutics, Kyoritsu College of Pharmacy, Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Hattori
authors.forename: M
authors.initials: M
authors.lastname: Muta
authors.forename: M
authors.initials: M
authors.lastname: Toi
authors.forename: H
authors.initials: H
authors.lastname: Iizasa
authors.forename: M
authors.initials: M
authors.lastname: Shinsei
authors.forename: T
authors.initials: T
authors.lastname: Terasaki
authors.forename: M
authors.initials: M
authors.lastname: Obinata
authors.forename: M
authors.initials: M
authors.lastname: Ueda
authors.forename: E
authors.initials: E
authors.lastname: Nakashima
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified; D000952:Antigens, Polyomavirus Transforming / Q000378:metabolism; D001854:Bone Marrow Cells / Q000166:cytology* / Q000378:metabolism*; D018929:Cell Culture Techniques / Q000379:methods; D002460:Cell Line / Q000166:cytology* / Q000378:metabolism*; D004727:Endothelium / Q000166:cytology* / Q000378:metabolism*; D005260:Female; D006412:Hematopoietic Stem Cells / Q000378:metabolism*; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D051381:Rats; D020794:Receptor Protein-Tyrosine Kinases / Q000378:metabolism; D042810:Receptor, TIE-1; D042787:Receptor, TIE-2; D011956:Receptors, Cell Surface / Q000378:metabolism; D017978:Receptors, Growth Factor / Q000378:metabolism; D042764:Receptors, TIE; D040262:Receptors, Vascular Endothelial Growth Factor; D040281:Vascular Endothelial Growth Factor Receptor-1; D014841:von Willebrand Factor / Q000378:metabolism
chemical_list: D000952:Antigens, Polyomavirus Transforming; D011518:Proto-Oncogene Proteins; D011956:Receptors, Cell Surface; D017978:Receptors, Growth Factor; D014841:von Willebrand Factor; D020794:Receptor Protein-Tyrosine Kinases; D042810:Receptor, TIE-1; D042787:Receptor, TIE-2; D042764:Receptors, TIE; D040262:Receptors, Vascular Endothelial Growth Factor; D040281:Vascular Endothelial Growth Factor Receptor-1